Skip to main content
Top
Published in: International Journal of Legal Medicine 6/2008

01-11-2008 | Original Article

Postmortem serum erythropoietin levels in establishing the cause of death and survival time at medicolegal autopsy

Authors: L. Quan, B.-L. Zhu, T. Ishikawa, T. Michiue, D. Zhao, D.-R. Li, M. Ogawa, H. Maeda

Published in: International Journal of Legal Medicine | Issue 6/2008

Login to get access

Abstract

Circulating erythropoietin (EPO) is mainly produced in the kidneys, depending on blood oxygen level. The present study investigated the postmortem serum EPO levels with regard to the cause of death and survival time. Serial medicolegal autopsy cases of postmortem time within 48 h (n = 536) were examined. Serum EPO levels were within the clinical reference range in most cases. Uremic patients with medical administration of an EPO agent (n = 11) showed a markedly high level (140–4,850 mU/ml; median, 1,798 mU/ml). Otherwise, an elevation in serum EPO level (>30 mU/ml) was mainly seen in protracted deaths due to blunt injury and fire fatality, depending on the survival time (r = 0.69, p < 0.0001, and r = 0.45, p < 0.0001, respectively), and in subacute deaths from gastrointestinal bleeding and infectious diseases. However, mildly to moderately elevated serum EPO levels were sporadically found in acute deaths due to mechanical asphyxiation, fire fatality, and acute ischemic heart disease, and in fatal hypothermia cases, especially for elderly subjects. Protracted deaths due to mechanical asphyxiation and ischemic heart disease did not show any survival time-dependent increase in serum EPO level (p > 0.05). EPO was immunohistochemically detected in the tubular epithelia and interstitial cells, showing no evident difference among the causes of death, independent of survival time or serum level. These findings suggest that serum EPO can be used as a marker for investigating anemia and/or hypoxia as a consequence of fatal insult in subacute or prolonged deaths, or a predisposition to traumatic deaths or fatal heart attacks in acute deaths.
Literature
1.
go back to reference Bohnert M, Schulz K, Belenkaia L, Liehr AW (2008) Re-oxygenation of haemoglobin in livores after post-mortem exposure to a cold environment. Int J Legal Med 122:91–96PubMedCrossRef Bohnert M, Schulz K, Belenkaia L, Liehr AW (2008) Re-oxygenation of haemoglobin in livores after post-mortem exposure to a cold environment. Int J Legal Med 122:91–96PubMedCrossRef
2.
go back to reference Wilke N, JanBen H, Fahrenhorst C et al (2007) Postmortem determination of concentrations of stress hormones in various body fluids-is there a dependency between adrenaline/noradrenaline quotient, cause of death and agony time? Int J Legal Med 121:385–394PubMedCrossRef Wilke N, JanBen H, Fahrenhorst C et al (2007) Postmortem determination of concentrations of stress hormones in various body fluids-is there a dependency between adrenaline/noradrenaline quotient, cause of death and agony time? Int J Legal Med 121:385–394PubMedCrossRef
3.
go back to reference Mimasaka S, Ohtsu Y, Tsunenari S, Funayama M (2006) Postmortem cytokine levels and severity of traumatic injuries. Int J Legal Med 120:265–270PubMedCrossRef Mimasaka S, Ohtsu Y, Tsunenari S, Funayama M (2006) Postmortem cytokine levels and severity of traumatic injuries. Int J Legal Med 120:265–270PubMedCrossRef
4.
go back to reference Zhu BL, Ishikawa T, Michiue T et al (2007) Postmortem serum catecholamine levels in relation to the cause of death. Forensic Sci Int 173:122–129PubMedCrossRef Zhu BL, Ishikawa T, Michiue T et al (2007) Postmortem serum catecholamine levels in relation to the cause of death. Forensic Sci Int 173:122–129PubMedCrossRef
6.
go back to reference Ishikawa T, Zhu BL, Miyaishi S, Ishizu H, Maeda H (2007) Increase in clusterin-containing follicles in the adenohypophysis of drug abusers. Int J Legal Med 121:395–402PubMedCrossRef Ishikawa T, Zhu BL, Miyaishi S, Ishizu H, Maeda H (2007) Increase in clusterin-containing follicles in the adenohypophysis of drug abusers. Int J Legal Med 121:395–402PubMedCrossRef
7.
go back to reference Zhu BL, Ishikawa T, Michiue T et al (2007) Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies. Int J Legal Med 121:28–35PubMedCrossRef Zhu BL, Ishikawa T, Michiue T et al (2007) Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies. Int J Legal Med 121:28–35PubMedCrossRef
8.
go back to reference Zhao D, Ishikawa T, Quan L et al (2008) Tissue-specific differences in mRNA quantification of glucose transporter 1 and vascular endothelial growth factor with special regard to death investigations of fatal injuries. Forensic Sci Int 177:176–183PubMedCrossRef Zhao D, Ishikawa T, Quan L et al (2008) Tissue-specific differences in mRNA quantification of glucose transporter 1 and vascular endothelial growth factor with special regard to death investigations of fatal injuries. Forensic Sci Int 177:176–183PubMedCrossRef
9.
go back to reference Zhao D, Zhu BL, Ishikawa T, Li DR, Michiue T, Maeda H (2006) Quantitative RT-PCR assays of hypoxia-inducible factor-1alpha, erythropoietin and vascular endothelial growth factor mRNA transcripts in the kidneys with regard to the cause of death in medicolegal autopsy. Legal Med 8:258–263PubMedCrossRef Zhao D, Zhu BL, Ishikawa T, Li DR, Michiue T, Maeda H (2006) Quantitative RT-PCR assays of hypoxia-inducible factor-1alpha, erythropoietin and vascular endothelial growth factor mRNA transcripts in the kidneys with regard to the cause of death in medicolegal autopsy. Legal Med 8:258–263PubMedCrossRef
10.
go back to reference Zhu BL, Tanaka S, Ishikawa T et al (2008) Forensic pathological investigation of myocardial hypoxia-inducible factor-1 alpha, erythropoietin and vascular endothelial growth factor in cardiac death. Legal Med 10:11–19PubMedCrossRef Zhu BL, Tanaka S, Ishikawa T et al (2008) Forensic pathological investigation of myocardial hypoxia-inducible factor-1 alpha, erythropoietin and vascular endothelial growth factor in cardiac death. Legal Med 10:11–19PubMedCrossRef
11.
go back to reference Jelkmann W (1992) Erythropoietin: structure, control of production, and function. Physiol Rev 72:449–489PubMed Jelkmann W (1992) Erythropoietin: structure, control of production, and function. Physiol Rev 72:449–489PubMed
12.
go back to reference Bunn HF, Poyton RO (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76:839–885PubMed Bunn HF, Poyton RO (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76:839–885PubMed
13.
14.
go back to reference Wintour EM, Butkus A, Earnest L, Pompolo S (1996) The erythropoietin gene is expressed strongly in the mammalian mesonephric kidney. Blood 88:3349–3353PubMed Wintour EM, Butkus A, Earnest L, Pompolo S (1996) The erythropoietin gene is expressed strongly in the mammalian mesonephric kidney. Blood 88:3349–3353PubMed
15.
go back to reference Koury ST, Koury MJ, Bondurant MC, Caro J, Graber SE (1989) Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 74:645–651PubMed Koury ST, Koury MJ, Bondurant MC, Caro J, Graber SE (1989) Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 74:645–651PubMed
16.
go back to reference Eckardt KU, Boutellier U, Kurtz A, Schopen M, Koller EA, Bauer C (1989) Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. J Appl Physiol 66:1785–1788PubMed Eckardt KU, Boutellier U, Kurtz A, Schopen M, Koller EA, Bauer C (1989) Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. J Appl Physiol 66:1785–1788PubMed
17.
go back to reference Katavetin P, Inagi R, Miyata T et al (2007) Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 359:928–934PubMedCrossRef Katavetin P, Inagi R, Miyata T et al (2007) Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 359:928–934PubMedCrossRef
18.
go back to reference Opasich C, Cazzola M, Scelsi L et al (2005) Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 26:2232–2237PubMedCrossRef Opasich C, Cazzola M, Scelsi L et al (2005) Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 26:2232–2237PubMedCrossRef
19.
go back to reference Koury MJ (2005) Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp Hematol 33:1263–1270PubMedCrossRef Koury MJ (2005) Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp Hematol 33:1263–1270PubMedCrossRef
20.
go back to reference Masaki Y, Oka N, Furuya H et al (1992) Clinical use of serum erythropoietin determination by recombigen EPO RIA kit. Jpn J Nucl Med 29:701–707 Masaki Y, Oka N, Furuya H et al (1992) Clinical use of serum erythropoietin determination by recombigen EPO RIA kit. Jpn J Nucl Med 29:701–707
21.
go back to reference Kato Y, Takagi C, Tanaka J, Masaki Y, Furuya H (1994) Effect of daily subcutaneous administration of recombinant erythropoietin on chronic anemia in rheumatoid arthritis. Int Med 33:193–197CrossRef Kato Y, Takagi C, Tanaka J, Masaki Y, Furuya H (1994) Effect of daily subcutaneous administration of recombinant erythropoietin on chronic anemia in rheumatoid arthritis. Int Med 33:193–197CrossRef
22.
go back to reference Flack CP, Woollen JW (1984) Prevention of interference by dextran with biuret-type assay of serum proteins. Clin Chem 30:559–561PubMed Flack CP, Woollen JW (1984) Prevention of interference by dextran with biuret-type assay of serum proteins. Clin Chem 30:559–561PubMed
23.
go back to reference Maeda H, Fukita K, Oritani S, Nagai K, Zhu BL (1996) Evaluation of post-mortem oxymetry in fire victims. Forensic Sci Int 81:201–209PubMedCrossRef Maeda H, Fukita K, Oritani S, Nagai K, Zhu BL (1996) Evaluation of post-mortem oxymetry in fire victims. Forensic Sci Int 81:201–209PubMedCrossRef
24.
go back to reference Maeda H, Fukita K, Oritani S, Ishida K, Zhu BL (1997) Evaluation of post-mortem oxymetry with reference to the causes of death. Forensic Sci Int 87:201–210PubMedCrossRef Maeda H, Fukita K, Oritani S, Ishida K, Zhu BL (1997) Evaluation of post-mortem oxymetry with reference to the causes of death. Forensic Sci Int 87:201–210PubMedCrossRef
25.
go back to reference Maeda H, Zhu BL, Ishikawa T et al (2006) Evaluation of post-mortem ethanol concentrations in pericardial fluid and bone marrow aspirate. Forensic Sci Int 161:141–143PubMedCrossRef Maeda H, Zhu BL, Ishikawa T et al (2006) Evaluation of post-mortem ethanol concentrations in pericardial fluid and bone marrow aspirate. Forensic Sci Int 161:141–143PubMedCrossRef
26.
go back to reference Oritani S, Zhu BL, Ishida K, Shimotouge K, Quan L, Fujita MQ, Maeda H (2000) Automated determination of carboxyhemoglobin contents in autopsy materials using head-space gas chromatography/mass spectrometry. Forensic Sci Int 113:375–379PubMedCrossRef Oritani S, Zhu BL, Ishida K, Shimotouge K, Quan L, Fujita MQ, Maeda H (2000) Automated determination of carboxyhemoglobin contents in autopsy materials using head-space gas chromatography/mass spectrometry. Forensic Sci Int 113:375–379PubMedCrossRef
27.
go back to reference Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843PubMed Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843PubMed
28.
go back to reference Maxwell PH, Osmond MK, Pugh CW et al (1993) Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44:1149–1162PubMedCrossRef Maxwell PH, Osmond MK, Pugh CW et al (1993) Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44:1149–1162PubMedCrossRef
29.
go back to reference Koury ST, Bondurant MC, Koury MJ (1988) Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 71:524–527PubMed Koury ST, Bondurant MC, Koury MJ (1988) Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 71:524–527PubMed
30.
go back to reference Schuster SJ, Koury ST, Bohrer M, Salceda S, Caro J (1992) Cellular sites of extrarenal and renal erythropoietin production in anaemic rats. Br J Haematol 81:153–159PubMedCrossRef Schuster SJ, Koury ST, Bohrer M, Salceda S, Caro J (1992) Cellular sites of extrarenal and renal erythropoietin production in anaemic rats. Br J Haematol 81:153–159PubMedCrossRef
31.
go back to reference Shih LY, Huang JY (1998) End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis. Nephron 79:142–147PubMedCrossRef Shih LY, Huang JY (1998) End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis. Nephron 79:142–147PubMedCrossRef
32.
go back to reference Macdougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Browne J, Egrie J (1999) Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Nephrol 10:2392–2395PubMed Macdougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Browne J, Egrie J (1999) Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Nephrol 10:2392–2395PubMed
33.
go back to reference Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C (2004) Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22:63–69PubMedCrossRef Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C (2004) Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22:63–69PubMedCrossRef
34.
go back to reference Hobisch-Hagen P, Wiedermann F, Mayr A, Fries D et al (2001) Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med 29:743–747PubMedCrossRef Hobisch-Hagen P, Wiedermann F, Mayr A, Fries D et al (2001) Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med 29:743–747PubMedCrossRef
35.
go back to reference von Ahsen N, Müller C, Serke S, Frei U, Eckardt KU (1999) Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 27:2630–2639CrossRef von Ahsen N, Müller C, Serke S, Frei U, Eckardt KU (1999) Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 27:2630–2639CrossRef
36.
go back to reference Pousada L, Fiorito J, Smyth C (1990) Erythropoietin and anemia of gastrointestinal bleeding in a Jehovah’s Witness. Ann Intern Med 112:552PubMed Pousada L, Fiorito J, Smyth C (1990) Erythropoietin and anemia of gastrointestinal bleeding in a Jehovah’s Witness. Ann Intern Med 112:552PubMed
37.
go back to reference Fischer R, Simmerlein R, Huber RM, Schiffl H, Lang SM (2007) Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatr Pulmonol 42:1193–1197PubMedCrossRef Fischer R, Simmerlein R, Huber RM, Schiffl H, Lang SM (2007) Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatr Pulmonol 42:1193–1197PubMedCrossRef
38.
go back to reference Tassiopoulos S, Kontos A, Konstantopoulos K et al (2001) Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 95:471–475PubMedCrossRef Tassiopoulos S, Kontos A, Konstantopoulos K et al (2001) Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 95:471–475PubMedCrossRef
39.
go back to reference Linksvan der Meer P, van Veldhuisen DJ, Januzzi JL (2008) Erythropoietin in cardiovascular diseases: exploring new avenues. Clin Sci (Lond) 114:289–291CrossRef Linksvan der Meer P, van Veldhuisen DJ, Januzzi JL (2008) Erythropoietin in cardiovascular diseases: exploring new avenues. Clin Sci (Lond) 114:289–291CrossRef
40.
go back to reference Singh AK, Szczech L, Tang KL, CHOIR Investigators et al (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355:2085–2098PubMedCrossRef Singh AK, Szczech L, Tang KL, CHOIR Investigators et al (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355:2085–2098PubMedCrossRef
Metadata
Title
Postmortem serum erythropoietin levels in establishing the cause of death and survival time at medicolegal autopsy
Authors
L. Quan
B.-L. Zhu
T. Ishikawa
T. Michiue
D. Zhao
D.-R. Li
M. Ogawa
H. Maeda
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
International Journal of Legal Medicine / Issue 6/2008
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-008-0276-9

Other articles of this Issue 6/2008

International Journal of Legal Medicine 6/2008 Go to the issue